The problems with anticancer therapy are resistance and toxicity. From 3000 Cisplatin
derivatives tested as antitumor agents, most of them have been rejected, due to toxicity. The …

Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …

The 5‐year overall survival rate of a patient with unresectable metastatic colorectal cancer is
poor at approximately 14%. Similarly, historical data on liver transplantation (LT) in those …

The majority of patients with metastatic colorectal cancer (CRC) to the liver are not
amenable to curative-intent surgery or thermal ablation; there is a need for alternative …

Background Transarterial radioembolisation (TARE) with Yttrium-90 resin microspheres is a
treatment option for patients with metastatic colorectal cancer in the liver (mCRC). A better …

Simple Summary Liver metastases occur in almost half of patients with colorectal cancer,
either at the time of presentation (synchronous) or eventually as a metachronous recurrence …

PURPOSE To develop a multidisciplinary consensus for high quality multidisciplinary
implementation of brachytherapy using Yttrium-90 (90 Y) microspheres transarterial …

An estimated 70% of patients with colorectal cancer will develop liver metastases during the
course of their disease. While the first-line treatment for hepatic metastases is resection …

The following is an overview of the treatment strategies and the prognostic factors to
consider in the therapeutic choice of patients characterized by solitary colorectal liver …

Transarterial radioembolization (TARE) with yttrium-90 (Y90) is a promising alternative
strategy to treat liver tumors and liver metastasis from colorectal cancer (CRC), as it …